Cardiology, University Hospital
Zurich, 8091, Switzerland
NCT Number: NCT00657436
The purpose of the study is the evaluation of multiple biomarkers related to acute coronary syndromes, including myeloid-related protein 8/14 (MRP 8/14), along with established clinical markers, for early diagnosis and risk stratification in patients presenting with acute chest pain at the emergency department.
Study hypothesis: MRP 8/14, alone or together with other established or new biomarkers, increases the earliness, sensitivity, and specificity of diagnosing acute coronary syndromes.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Zurich, 8091, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Emergency room and/or hospital stay
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
University of Zurich
Other
Study of Myeloid-related Protein 8/14 and Additional Biomarkers (Multi Marker Approach) for Early Diagnosis and Risk Stratification in Patients Presenting With Acute Chest Pain at the Emergency Department
Acronym: MyRiAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04125992
Acute Coronary Syndrome, Angina Pectoris
Nablus, Palestinian Territories
View Trial DetailsNCT01559467
Acute Coronary Syndrome, Arterial Occlusive Diseases
Maastricht, Limburg, Netherlands
View Trial DetailsNCT05248165
Acute Coronary Syndrome, Arterial Occlusive Diseases
Naples, Italy
View Trial DetailsNCT05238103
Arterial Occlusive Diseases, Arteriosclerosis
Baltimore, Maryland, United States
View Trial Details